Annual report
7776.TEDINET S100T4XQ
Period2023-01-01 → 2023-12-31
Filed2024-03-28
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 13 passed
Key figures · 100
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥190m | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥126m | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥162m | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥199m | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥276m | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥698m | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | −¥743m | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | −¥710m | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥754m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥887m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥866m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥745m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥729m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥786m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥787m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥846m | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥759m | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income (owners) | −¥915m | 2021-01-01 → 2021-12-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥784m | 2020-01-01 → 2020-12-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥782m | 2019-01-01 → 2019-12-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥847m | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | −¥760m | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥913m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥768m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥783m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.5bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.4bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥301m | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥366m | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.2bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.5bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.3bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2023-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥847m | at 2021-12-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥931m | at 2021-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2020-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.1bn | at 2019-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥779m | 2023-01-01 → 2023-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥718m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥817m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥701m | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥578m | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥56m | 2023-01-01 → 2023-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥62m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥110m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13m | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥133m | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.8bn | 2023-01-01 → 2023-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥882m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥397m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥721m | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-29.43 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.31 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-53.18 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-53.08 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-55.31 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.19 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.6 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.68 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥68.08 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥47.26 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥56.44 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥57.43 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥93.85 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥95.7 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥102.24 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥103.88 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 86.9% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.0% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.5% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.1% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.3% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 31,459,019 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,422,619 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,759,419 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,008,319 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,981,819 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 35 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 30 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 44 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 40 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 40 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥21m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥2.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥197m |
| Cell Sheet Regenerative Medicinereportable segment | employees | at 2023-12-31 | 20 pure |
| Cell Sheet Regenerative Medicinereportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥8m |
| Cell Sheet Regenerative Medicinereportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥8m |
| Cell Sheet Regenerative Medicinereportable segment | segment assets | at 2023-12-31 | ¥65m |
| Cell Sheet Regenerative Medicinereportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥469m |
| Laboratory Consumables And Equipmentreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥770,000 |
| Laboratory Consumables And Equipmentreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥8m |
| Laboratory Consumables And Equipmentreportable segment | employees | at 2023-12-31 | 10 pure |
| Laboratory Consumables And Equipmentreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥182m |
| Laboratory Consumables And Equipmentreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥182m |
| Laboratory Consumables And Equipmentreportable segment | segment assets | at 2023-12-31 | ¥133m |
| Laboratory Consumables And Equipmentreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥32m |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥770,000 |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥8m |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥190m |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥190m |
| —segment total | segment assets | at 2023-12-31 | ¥198m |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | −¥501m |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥190m |
| Cell Sheet Regenerative Medicinereportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥10m |
| Cell Sheet Regenerative Medicinereportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥10m |
| Cell Sheet Regenerative Medicinereportable segment | segment assets | at 2022-12-31 | ¥82m |
| Cell Sheet Regenerative Medicinereportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥463m |
| Laboratory Consumables And Equipmentreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥563,000 |
| Laboratory Consumables And Equipmentreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥8m |
| Laboratory Consumables And Equipmentreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥116m |
| Laboratory Consumables And Equipmentreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥116m |
| Laboratory Consumables And Equipmentreportable segment | segment assets | at 2022-12-31 | ¥196m |
| Laboratory Consumables And Equipmentreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥90m |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥563,000 |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥8m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥126m |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥126m |
| —segment total | segment assets | at 2022-12-31 | ¥277m |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | −¥553m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 992
| Item | Context | Value | Unit |
|---|---|---|---|
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 77760 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社セルシード | |
| Filer name in english | FilingDateInstant | CellSeed Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2023-01-01 | |
| Current period end date | FilingDateInstant | 2023-12-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Comparative period end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Policy on human resource development and improvement of internal environment strategy (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Description of metrics related to policy on human resource development and improvement of internal environment and targets and results using such metrics metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Material matters relating to going concern etc business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |